By visiting our website or using services provided by Sai Life Sciences, you are accepting the practices described in the Privacy Policy.

We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. By continuing to use this website, you agree that we may store and access cookies on your device.

By clicking “I Accept”, you confirm that you are above the age of 16, that you have read and understood the Cookies Usage and the Privacy Policy, and that you agree to the collection, use and processing of your Personal Information by Sai Life in accordance with said policies.

I accept

Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2019.09.20

20 years of Sai Life Sciences

Sai Life Sciences turns 20!

For a company that started in a small laboratory with two fume hoods, Sai Life Sciences has come a long way in its quest of bringing new medicines to life. Over the past two decades, the company has enabled several innovator pharma and biotech customers discover, develop and manufacture innovative new medicines, and make the lives of patients better.

Today, Sai Life Sciences is among the fastest growing CDMOs in India. Backed by committed investors TPG Capital and HBM Partners, the company is making significant investments in augmenting its capabilities to address the growing demand from innovator companies globally. The next 20 years promise to be even more exciting!

Share article

More News

2025.11.27

India is evolving from being a tactical supplier to a strategic partner to global pharma

Krishna Kanumuri, MD & CEO of Sai Life Sciences, was recently interviewed by Pharmaceutical Executive for its feature on next-generation CDMOs. In the interview, he shares insights on how Indian CDMOs are evolving from tactical suppliers to strategic partners, the shifting global supply-chain landscape, and how Sai Life Sciences is preparing for the opportunities and […]
Read more

2025.11.27

Decoding the Signals of Life: CDFD’s Dr. Rashna Bhandari visits Sai

Dr. Rashna Bhandari, Principal Investigator at the Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, recently visited our Sai Life Sciences campus to deliver an insightful masterclass on “Phosphate-rich biomolecules in cell signalling.” In her session, Dr. Bhandari explored how phosphate-rich molecules act as vital messengers that regulate cellular communication and coordination. She explained how […]
Read more

2025.11.08

SLSC_Sankalp

Sai Life Sciences Launches Child Safety Awareness Program in Government Schools in Hyderabad with Sankalp

Raising awareness around child safety requires sensitivity and a collective effort to help children recognize unsafe situations and know how to respond. Guided by this purpose, Sai Life Sciences, in partnership with Sankalp NGO, has launched a Child Sexual Abuse Prevention Program across ten government schools in Gachibowli, Hyderabad. The program features two age-appropriate curriculums […]
Read more

2025.11.07

Sai Life Sciences Limited

Sai Life Sciences Limited sustains growth momentum in Q2FY26

Revenue up by 36%; EBITDA up by 43%; Net Profit up by 100% Hyderabad, November 06, 2025: Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), one of India’s fastest growing Contract Research, Development and Manufacturing Organizations (CRDMO) announced its financial results for the second quarter and half year ended September 2025. Financial Performance: Particulars […]
Read more

2025.11.05

Where Nature Inspires Innovation: University of Kansas Prof. Apurba Dutta visits Sai

Dr. Apurba Dutta, Associate Professor at Department of Medicinal Chemistry, University of Kansas, USA, recently visited our Sai Life Sciences campus to deliver a masterclass on “A serine-derived second-generation chiron: Applications in the synthesis of natural and nature-like molecular scaffolds.”During the session, he explored how simple natural molecules can serve as versatile building blocks for […]
Read more